Image

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Testing new treatments for wet age-related macular degeneration.

Recruiting
50 years and older
All
Phase 3

This study is examining whether two new treatments, Tarcocimab Tedromer and Tabirafusp Tedromer, are safe and effective for those with neovascular (wet) age-related macular degeneration (wAMD). This eye condition can cause vision loss. The study compares these treatments to a medication called Aflibercept, which is already used for wAMD. People who want to join must have a condition called choroidal neovascularization (CNV) due to age-related macular degeneration. They should not have had any treatment for it before. You must have a certain vision range, measured by a test called BCVA, which checks how many letters you can read on an eye chart. You can’t join if you have very poor vision in the non-study eye or a large area of eye damage.

  • Study Duration: The study might last several months, with regular visits.
  • Compensation: Participants may receive reimbursement for time and travel.
  • Risks: There might be side effects or risks similar to those of other eye treatments.
Study details
    Wet Age-related Macular Degeneration

NCT06556368

Kodiak Sciences Inc

8 February 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.